Skip to main content

Advertisement

SpringerLink
Log in

Primary central nervous system lymphoma in Japan

A retrospective, co-operative study by CNS-Lymphoma Study Group in Japan

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

This manuscript reports the results of the first cooperative study on primary central nervous system lymphoma (PCNSL) in Japan. Of 196 patients registered, 170 were judged as having PCNSL. No patients were immunocompromised. Of the 170 patients with PCNSL, 93 were males and 77 were females. The mean was 56.7 years. One hundred and nineteen tumors were confirmed histopathologically, and 51 were diagnosed by neuroimaging alone. All the tumors were non-Hodgkin's lymphoma. According to the Working Formulation for Clinical Usage (WF), 96 out of 119 tumors were classifiable: 53 were diffuse large cell type (55.2%), 17 immunoblastic type (17.7%), 9 diffuse small cleaved type (9.4%), 6 diffuse mixed type (6.3%), 5 polymorphous type (5.2%), 5 small lymphocytic type (5.2%) and 1 small non-cleaved type (1.0%). Of 21 tumors studied immunohistochemically, 18 were B-cell type and 3 were T-cell type. Irradiated patients (144) survived significantly longer than non-irradiated patients, (median survival time, MST: 19.2 and 2.7 months, respectively; p<0.001). There was a remarkable difference in survival among patients of the intermediate lymphomas; MST (18 months) of patients with large cell lymphoma was significantly shorter than MST (over 96 months) of patients with other intermediate grade lymphomas (small cleaved and mixed) (p < 0.001) and had no significant difference from MST (9 months) of patients with high grade lymphomas. If patients were irradiated with more than 40 Gy, higher doses and different modes of irradiation brought no further survival advantage. Chemotherapy was performed in 87 of 144 irradiated patients (60.4%). No regimens were effective in prolonging survival. Of 144 irradiated patients, a complete or partial response to initial treatment was demonstrated in 91 (63.2%) and 43 patients (29.9%), respectively. Improvement in performance status was confirmed in 82 patients (57.0%). Despite a good response to initial treatments. 88 out of 144 evaluable patients have died of PCNSL (MST: 19 months). Multivariate analysis based on the Cox hazard model revealed that histology of tumor, age at onset, performance status, and radiotherapy were prognostic factors. Neither chemotherapy nor mode of surgery was a beneficial factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Aozasa K, Ohsawa M, Yamabe H, Shima N, Kirimoto K, Yamane T, Tujimoto M, Kobayashi Y, Kurata A, Osada H, Konishi F, Nagashima K: Malignant lymphoma of the central nervous system in Japan: histologic and immunohistologic studies. Int J Cancer 45: 632–636, 1990

    PubMed  Google Scholar 

  2. Brain tumor registry of Japan. The committee of brain tumor registry in Japan. Kazuhiro Nomura, M.D., Chairman, Department of Neurosurgery, National Cancer Hospital, Chuo-Ku Tokyo 104, Japan. Vol 8. 1993

    Google Scholar 

  3. Jellinger K, Radaskiewicz TH, Slowik F: Primary malignant lymphomas of the central nervous system in man. Acta Neuropathol Suppl 6: 95–102, 1975

    Google Scholar 

  4. Tanaka T, Nishimoto A, Doi A, Nagao S, Hujita M, Sezaki T, Yumoto T: Primary intracranial malignant lymphomas with particular reference to their pathogenesis. Acta Pathol Jpn 27: 927–940, 1977

    PubMed  Google Scholar 

  5. Woodman R, Shin K, Pineo G: Primary non-Hodgkin's lymphoma of the brain. A review. Medicine 64: 425–430, 1986

    Google Scholar 

  6. Zimmerman HM: Malignant lymphomas of the nervous system. Acta Neuropathol suppl 6: 69–74, 1975

    Google Scholar 

  7. Aozasa K, Tsujimoto M, Sakurai M, Honda M, Yamashita K, Hanada M, Sugimoto A: Non-Hodgkin's lymphoma in Osaka, Japan. Eur J Cancer Clin Oncol 21: 487–492, 1985

    PubMed  Google Scholar 

  8. Freeman CR, Berg JW, Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 29: 252–260, 1972

    PubMed  Google Scholar 

  9. Mendenhall NP, Thar TL, Agee OF, Harty-Golder B, Ballinger WE Jr, Million RR: Primary lymphoma of the central nervous system. Computerized tomography scan characteristics and treatment results in 12 cases. Cancer 52: 1993–2000, 1983

    PubMed  Google Scholar 

  10. Filipovich AH, Heinitz KJ, Robison LL, Frizzera G: The Immunodeficiency Cancer Registry. A research resource. Am J Pediatr Hematol Oncol 9: 183–184, 1987

    PubMed  Google Scholar 

  11. Gatti RA, Good RA: Occurrence of malignancy in immunodeficiency diseases. A literature review. Cancer 28: 89–98, 1971

    PubMed  Google Scholar 

  12. Pattengale PK, Taylor CR, Panke T, Tatter, McCormick RA, Rawlinson DG, Davis RL: Selective immunodeficiency and malignant lymphoma of the central nervous system. Possible relationship to the Epstein-Barr virus. Acta Neuropathol 48: 165–169, 1979

    PubMed  Google Scholar 

  13. Penn I: Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83: 492–502, 1978

    PubMed  Google Scholar 

  14. Penn I: The incidence of malignancies in transplant recipients. Transpl Proc 7: 323–326, 1975

    Google Scholar 

  15. Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum ML: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73: 206–211, 1990

    PubMed  Google Scholar 

  16. Levy RM, Bredesen DE, Rosenblum ML: Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 62: 475–495, 1985

    PubMed  Google Scholar 

  17. Remick SC, Diamond C, Miglizzi JA, Solis O, Wagner H Jr, Hasse RF, Ruckdeschel JC: Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature. Medicine 69: 345–360, 1990

    PubMed  Google Scholar 

  18. Rosenblum ML, Levy RM, Bredeson DE: Neurosurgical implications of the acquired immunodeficiency syndrome (AIDS). Clin Neurosurg 34: 419–445, 1988

    PubMed  Google Scholar 

  19. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel S, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461–2465, 1988

    PubMed  Google Scholar 

  20. Garson JA, Bourne SP, Allan PM, Leather C, Brownell DB, Coakham HB: Immunohistochemical diagnosis of primary brain lymphoma using monoclonal antibodies: Confirmation of B-cell origin. Neuropathol Applied Neurobiol 14: 19–37, 1988

    Google Scholar 

  21. O'Sullivan MG, Whittle IR, Gregor A, Ironside JW: Increasing incidence of CNS primary malignant lymphoma in southeast Scotland. Lancet 338: 895–896, 1991

    PubMed  Google Scholar 

  22. The Non-Hodgkin's Lymphoma Pathologic Classification Project: The National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 49: 2112–2139, 1982

    Google Scholar 

  23. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457–481, 1958

    Google Scholar 

  24. Cox DR: Regression models and life tables. J Royal Stat Soc (Series B) 34: 187–220, 1972

    Google Scholar 

  25. Cellerier P, Chiras J, Gray F, Metzger J, Bories J: Computed tomography in primary lymphoma of the brain. Neuroradiology 26: 485–492, 1984

    PubMed  Google Scholar 

  26. Holtås S, Nyman U, Cronqvist S: Computed tomography of malignant lymphoma of the brain. Neuoradiology 26: 33–38, 1984

    Google Scholar 

  27. Jack CR, Reese DF, Scheithauer BW: Radiographic findings in 32 cases of primary CNS lymphoma: AJNR 6: 899–904, 1985

    Google Scholar 

  28. Jack CR, O'Neill BP, Banks PM, Reese DF: Central nervous system lymphoma: Histologic types and CT appearance. Radiology 167: 211–215, 1988

    PubMed  Google Scholar 

  29. Thomas M, Macpherson P: Computed tomography of intracranial lymphoma. Clinical Radiology 33: 331–336, 1982

    PubMed  Google Scholar 

  30. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross G: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277–1280, 1990

    PubMed  Google Scholar 

  31. Berry MP, Simpson WJ: Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radial Oncol Biol Phys 7: 55–59, 1981

    Google Scholar 

  32. Bogdahn U, Bogdahn S, Mertens HG, Dommasch D, Wodarz R, Wünsch PH, Kühl P, Richter E: Primary non-Hodgkin's lymphomas of the CNS. Acta Neurol Scand 73: 602–614, 1986

    PubMed  Google Scholar 

  33. Burstein SD, Kernohan JW, Uihlein A: Neoplasms of the reticuloendothelial system of the brain. Cancer 3: 289–303, 1963

    Google Scholar 

  34. Freeman CR, Shustik C, Brisson ML, Meagher-Villemure K, Dylewski I: Primary malignant lymphoma of the central nervous system. Cancer 58: 1106–1111, 1986

    PubMed  Google Scholar 

  35. Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis R: Primary malignant lymphomas of the central nervous system. Cancer 34: 1293–1302, 1974

    PubMed  Google Scholar 

  36. Hochberg FH, Miller DC: Primary central nervous system lymphoma. A review. J Neurosurg 68: 835–853, 1988

    PubMed  Google Scholar 

  37. Littman P, Wang CC: Reticulum cell sarcoma of the brain. A review of the literature and a study of 19 cases. Cancer 35: 1412–1420, 1975

    PubMed  Google Scholar 

  38. Loeffler JS, Ervin TJ, Mauch P, Skarin A, Weinsten HJ, Canellos G, Cassady JR: Primary lymphomas of the central nervous system: patterns of failure and factors that influence survival. J Clin Oncol 3: 490–494, 1985

    PubMed  Google Scholar 

  39. Murray K, Kun L, Cox J: Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature. J Neurosurg 65: 600–607, 1986

    PubMed  Google Scholar 

  40. Neuwelt EA, Frenkel EP, Gumerlock MK, Braziel R, Dana B, Hill SA: Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective study. Cancer 58: 1609–1620, 1986

    PubMed  Google Scholar 

  41. Pollack IF, Lunsford LD, Flickinger JC, Dameshek HL: Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma. Cancer 63: 939–947, 1989

    PubMed  Google Scholar 

  42. Sagerman RH, Collier CH, King GA: Radiation therapy of microgliomas. Radiology 149: 567–570, 1983

    PubMed  Google Scholar 

  43. Schaumburg HH, Plank CR, Adams RD: The reticulum cell sarcoma-microglioma group of brain tumours. A consideration of their clinical features and therapy. Brain 95: 199–212, 1972

    PubMed  Google Scholar 

  44. Kolar OJ: Differential diagnostic aspects in malignant lymphomas involving the central nervous system. Acta Neuropath suppl 6: 181–186, 1975

    Google Scholar 

  45. Rampen FHJ, van Andel JG, Sizoo W, Unnik JAM van: Radiation therapy in primary non-Hodgkin's lymphomas of the CNS. Eur J Cancer 16: 177–184, 1980

    PubMed  Google Scholar 

  46. Sagerman RH, Cassady JR, Chang CH: Radiation therapy for intracranial lymphoma. Radiology 88: 552–554, 1967

    PubMed  Google Scholar 

  47. DeAngelis LM, Yahalom J, Heinemann MH, Cirrincione C, Thaler HT, Krol G: Primary CNS lymphoma: Combined treatment with chemotherapy and radiotherapy. Neurology 40: 80–86, 1990

    PubMed  Google Scholar 

  48. Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman-Goldstein S, Braziel R, Dana B: Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function. J Clin Oncol 9: 1580–1590, 1991

    PubMed  Google Scholar 

  49. Kubota S, Hashimoto T, Kubo O, Hamada H, Okino M, Beppu T, Kitamura K: Two cases of intracerebral malignant lymphoma (Abstract in English). Noshinkeigeka 3: 67–73, 1975

    Google Scholar 

  50. Hayashi A, Kyuma Y, Kuwabara T, Fujitu K, Shinonaga M, Yamaguchi K, Sekido K, Chiba Y, Yamashita T, Oda M, Kuwana N, Fujino H: Management results of primary intracranial malignant lymphoma (Abstract in English). Noshinkeigeka 18: 715–720, 1990

    Google Scholar 

  51. Spillane JA, Kendall BE, Moseley IF: Cerebral lymphoma: clinical radiological correlation. J Neurol Neurosurg Psychiatry 45: 199–208, 1982

    PubMed  Google Scholar 

  52. Ebel EJ: Reticulosarcomas of the brain presenting as butterfly tumors. Possible implications for treatment. Europ Neurol 8: 333–338, 1972

    PubMed  Google Scholar 

  53. Epstein AL, Herman MM, Kim H, Dorfmann RF, Path MRC, Kaplan HS: Biology of the human malignant lymphoma. Intracranial heterotransplantation in the nude athymic mouse. Cancer 37: 2158–2176, 1976

    PubMed  Google Scholar 

  54. Ojeda VJ, Lee MA, Walters MNL, Vaughan RJ: Primary malignant lymphoma of the brain. A clinicopathologic study of five cases. Med J Aust 2: 146–150, 1983

    PubMed  Google Scholar 

  55. Helle TL, Britt RH, Colby TV: Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford. J Neurosurg 60: 94–103, 1984

    PubMed  Google Scholar 

  56. Gonzalez DG, Schuster-Uitterhoeve ALJ: Primary nonHodgkin's lymphoma of the central nervous system. Results of radiotherapy in 15 cases. Cancer 51: 2048–2052, 1983

    PubMed  Google Scholar 

  57. Watanabe M, Tanaka R, Takeda N, Washiyama K, Takahashi H: Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain. Neuroradiology 34: 36–42, 1992

    PubMed  Google Scholar 

  58. Niibe H, Tamaki Y, Watanabe S, Masaki N, Horiuchi J, Hayabuchi N, Kaneda K, Morita K: Primary malignant lymphoma of the central nervous system. Report of Japan Lymphoma Radiation Therapy Group (JLRTG) (in Japanese). Gan no Rinsho 34: 651–657, 1988

    PubMed  Google Scholar 

  59. Frank G, Ferracini R, Spagnolli F, Frank F, Gaist G, Lorenzini P, Ricci R: Primary intracranial lymphomas. Surg Neurol 23: 3–8, 1985

    PubMed  Google Scholar 

  60. Grote TH, Grosh WW, List AF, Wiley R, Cousar JB, Johnson DH: Primary lymphoma of the central nervous system. Am J Clin Oncol (CCT) 12(2): 93–100, 1989

    Google Scholar 

  61. Letendre L, Banks PM, Reese DF, Miller RH, Scanion PW, Kiely JM: Primary lymphoma of the central nervous system. Cancer 49: 939–943, 1982

    PubMed  Google Scholar 

  62. Gabbai AA, Hochberg FH, Linggood RM, Basher R, Hotleman K: High dose methotrexate for non-AIDS primary central nervous system lymphoma, report of 13 cases. J Neurosurg 70: 190–194, 1989

    PubMed  Google Scholar 

  63. Brada M, Dearnaley DD, Horwich A, Bloom HJG: Management of primary cerebral lymphoma with initial chemotherapy: preliminary results and comparison with patients treated with radiotherapy alone. Int J Radiation Oncology Biol Phy 18: 787–792, 1990

    Google Scholar 

  64. Kawakami Y, Tabuchi K, Ohnishi R, Asari S, Nishimoto A: Primary central nervous system lymphoma. J Neurosurg 62: 522–527, 1985

    PubMed  Google Scholar 

  65. Blasberg RG, Groothuis D, Molnar P: A review of hyperosmotic blood-brain barrier disruption in seven experimental brain tumor models. In: Johansson BB, Widner COH (eds) Pathophysiology of the Blood-Brain Barrier. Elsevier, New York, pp 197–220, 1990

    Google Scholar 

  66. Goldie JH, Coldman AJ: A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727–1733, 1979

    PubMed  Google Scholar 

  67. Hryniuk W, Bush H: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2: 1281–1288, 1984

    PubMed  Google Scholar 

  68. Chamberlain MC, Levin VA: Adjuvant chemotherapy for primary lymphoma of the central nervous system. Arch Neurol 47: 1113–1116, 1990

    PubMed  Google Scholar 

  69. Abelson HT, Kufe DW, Skarin AT, Major P, Ensminger W, Beardsley GP, Canellos GP: Treatment of central nervous system lymphoma with high dose methotrexate. Cancer Treat Rep 65: 137–140, 1981

    Google Scholar 

  70. Ervin T, Canellos GP: Successful treatment of recurrent primary central nervous system lymphoma with high-dose methotrexate. Cancer 45: 1556–1557, 1980

    PubMed  Google Scholar 

  71. Herbst KD, Corder MP, Justice GR: Successful therapy with methotrexate of a multicentric mixed lymphoma of the central nervous system. Cancer 38: 1476–1478, 1976

    PubMed  Google Scholar 

  72. Allen JC, Rosen G, Mehta BM, Horten B: Leukoencephalopathy following high-dose IV methotrexate chemotherapy with leucovorin rescue. Cancer Treat Rep 64: 1261–1273, 1980

    PubMed  Google Scholar 

  73. Mackintosh FR, Colby TV, Podolsky WJ, Burke JS, Hoppe RT, Rosenfelt FP, Rosenberg SA, Kaplan HS: Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases. Cancer 49: 586–595, 1982

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. CNS-Lymphoma Study Group in Japan (CNS-LSG), Japan

    Toru Hayakawa, Kintomo Takakura, Hiroshi Abe, Takashi Yoshimoto, Ryuichi Tanaka, Kenichiro Sugita, Haruhiko Kikuchi, Tohru Uozumi, Tomokatsu Hori, Hitoshi Fukui, Yukitaka Ushio, Kazuhiro Nomura, Masao Matsutani, Noboru Mohri, Toshiro Kumanishi, Katsuyuki Aozasa & Kazuo Nagashima

Authors
  1. Toru Hayakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kintomo Takakura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hiroshi Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takashi Yoshimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ryuichi Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenichiro Sugita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haruhiko Kikuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tohru Uozumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tomokatsu Hori
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Hitoshi Fukui
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yukitaka Ushio
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Kazuhiro Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Masao Matsutani
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Noboru Mohri
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Toshiro Kumanishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Katsuyuki Aozasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Kazuo Nagashima
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hayakawa, T., Takakura, K., Abe, H. et al. Primary central nervous system lymphoma in Japan. J Neuro-Oncol 19, 197–215 (1994). https://doi.org/10.1007/BF01053274

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01053274

Key words

Search

Navigation